8-K: Cross Country Healthcare Reports Mixed Q4 and Full Year 2023 Results Amidst Market Normalization

Cross Country Healthcare's Q4 2023 results show a significant year-over-year revenue decline, though the company exceeded the high end of its guidance range, while also achieving a record year of cash flow from operations.

Summary

• Cross Country Healthcare announced its financial results for the fourth quarter and full year ended December 31, 2023.
• The company's Q4 revenue was $414 million, a 34% decrease year-over-year and a 6% decrease sequentially.
• Full year revenue reached $2.02 billion, a 28% decrease compared to the previous year.
• Net income attributable to common stockholders for Q4 was $9 million, a 77% decrease year-over-year, and $72.6 million for the full year, a 61% decrease year-over-year.
• Adjusted EBITDA for Q4 was $20.6 million, a 64% decrease year-over-year, and $144.4 million for the full year, a 52% decrease year-over-year.
• The company's cash flow from operations was $12.1 million for the quarter and a record $248.5 million for the year.
• Cross Country Healthcare repurchased 2.3 million shares for $57.6 million in 2023, representing 6.8% of shares outstanding.
• The company ended the year debt-free after repaying $73.9 million on its term loan and paying down its ABL.
• The company invested over $20 million in core technologies including Intellify and XperienceTM.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with significant year-over-year declines in revenue and profitability, but also highlights positive cash flow and strategic investments. The overall sentiment is cautiously negative due to the substantial financial downturn.

Positives

• The company exceeded its revenue guidance for the fourth quarter.
• Physician staffing saw a 26% year-over-year revenue increase.
• The company generated a record $248.5 million in cash flow from operations for the year.
• Cross Country Healthcare successfully paid off all debt, ending the year debt-free.
• The company invested significantly in technology, including Intellify and XperienceTM.
• The company repurchased a significant portion of its shares, demonstrating confidence in its value.

Negatives

• Consolidated revenue decreased by 34% year-over-year in Q4 and 28% for the full year.
• Net income attributable to common stockholders decreased by 77% year-over-year in Q4 and 61% for the full year.
• Adjusted EBITDA decreased by 64% year-over-year in Q4 and 52% for the full year.
• Nurse and Allied Staffing revenue decreased by 38% year-over-year in Q4.
• Average revenue per FTE per day in Nurse and Allied Staffing decreased from $510 to $414 year-over-year.

Risks

• The company faces challenges in the nurse and allied staffing segment due to client right-sizing and normalizing travel bill rates.
• The company's financial performance is subject to the overall macroeconomic environment, including inflation and interest rates.
• The company's ability to attract and retain qualified healthcare personnel is a risk.
• The company's performance is affected by the costs and availability of short-term housing for travel healthcare professionals.
• Cybersecurity risks and incidents could negatively impact the company's business.
• Government regulations and legislative initiatives could affect the company's operations.
• The company's ability to successfully implement its acquisition and development strategies is a risk.

Future Outlook

The company expects Q1 2024 revenue to be between $370 million and $380 million, a 39% to 41% decrease year-over-year, and adjusted EBITDA to be between $13 million and $18 million, a 65% to 75% decrease year-over-year. Adjusted EPS is expected to be between $0.15 and $0.25.

Management Comments

• John A. Martins, President and CEO, stated that the company is proud of its accomplishments in 2023, including the rollout of Intellify and growth in non-travel businesses.
• Management's goal for the coming year is to capitalize on investments, grow the client base, ramp up recent wins, and drive operational efficiency to expand margins.
• The company is well-positioned to make further strategic investments and accretive acquisitions to meet the evolving needs of its clients.

Industry Context

The results reflect a broader trend of normalization in the healthcare staffing industry after a period of high demand during the pandemic. The company's focus on technology and diversification into non-travel staffing areas aligns with industry trends towards more efficient and flexible workforce solutions.

Comparison to Industry Standards

• Cross Country Healthcare's revenue decline of 28% for the full year is significant, indicating a more pronounced impact from market normalization compared to some competitors.
• Competitors like AMN Healthcare have also reported revenue declines, but the magnitude of the decrease varies, suggesting different levels of exposure to the travel nurse market.
• The company's focus on technology investments is in line with industry trends, but the impact on future performance remains to be seen.
• The company's debt-free status is a positive differentiator compared to some competitors who may still carry significant debt.

Legal Proceedings

• The company incurred $1.1 million in legal fees to settle a wage and hour class action lawsuit.

Stakeholder Impact

• Shareholders will be impacted by the significant decrease in revenue and profitability.
• Employees may be affected by cost-saving initiatives and restructuring.
• Customers may see changes in service offerings as the company focuses on technology and non-travel staffing.
• Suppliers may be impacted by changes in the company's financial performance.
• Creditors are not impacted as the company is debt free.

Next Steps

• The company plans to capitalize on investments made in the business.
• The company aims to grow its client base and ramp up recent wins.
• The company intends to drive operational efficiency to expand margins.
• The company is positioned to make further strategic investments and accretive acquisitions.

Key Dates

Keywords

Healthcare Staffing, Nurse Staffing, Physician Staffing, EBITDA, Revenue, Financial Results, Workforce Solutions, Technology Investment, Debt Repayment, Share Repurchase